Kathleen Zhang, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Pfizer
    Topic: 
    Prostate cancer and cardiovascular disease
    Date added: 
    08/22/2022
    Relationship end date: 
    06/18/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    BridgeBio Pharma
    Topic: 
    Transthyretin cardiac amyloidosis
    Date added: 
    08/22/2022
    Relationship end date: 
    02/14/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Janssen Pharmaceuticals
    Topic: 
    Cardiac amyloidosis
    Date added: 
    08/22/2022
    Relationship end date: 
    01/01/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Alnylam Pharmaceuticals
    Topic: 
    Cardiac amyloidosis
    Date added: 
    08/22/2022
    Relationship end date: 
    01/01/2022
Return to 234 Cardio-Oncology Conference: "Arrhythmias and Structural Cardiac Abnormalities in Patients with Cancer" (021023)